Bone Biologics (BBLG) Accounts Payables (2013 - 2025)
Bone Biologics (BBLG) reported Accounts Payables of $417884.0 for Q4 2025, up 12.02% year-over-year from $373042.0 in Q4 2024, and up 25.46% quarter-over-quarter from $333081.0 in Q3 2025.
Bone Biologics (BBLG) Accounts Payables (2013 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 13 years of Accounts Payables data on file, last reported at $417884.0 in Q4 2025.
- Accounts Payables for Q4 2025 came in at $417884.0, up 12.02% year-over-year; the trailing twelve-month figure through Dec 2025 was $417884.0 (up 12.02% YoY), and the FY2025 annual result was $417884.0, up 12.02% from the prior year.
- Accounts Payables advanced to $417884.0 in Q4 2025 per BBLG's latest filing, from $333081.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $2.3 million in Q1 2023 and troughed at $54913.0 in Q1 2022.
- A 5-year average of $478146.7 and a median of $290462.0 in 2025 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables jumped 4050.55% in 2023, then tumbled 93.59% in 2024.
- A 5-year view of Accounts Payables shows it stood at $99909.0 in 2021, then grew by 4.88% to $104786.0 in 2022, then surged by 244.19% to $360662.0 in 2023, then rose by 3.43% to $373042.0 in 2024, then advanced by 12.02% to $417884.0 in 2025.
- Business Quant data shows BBLG's Accounts Payables at $417884.0 in Q4 2025, $333081.0 in Q3 2025, and $403729.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 8.64 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 34.55 Mn |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | 417,884.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 417,884.00 |
| Sep 30, 2025 | 333,081.00 |
| Jun 30, 2025 | 403,729.00 |
| Mar 31, 2025 | 247,843.00 |
| Dec 31, 2024 | 373,042.00 |
| Sep 30, 2024 | 190,057.00 |
| Jun 30, 2024 | 231,872.00 |
| Mar 31, 2024 | 146,186.00 |
| Dec 31, 2023 | 360,662.00 |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | 2.28 Mn |
| Dec 31, 2022 | 104,786.00 |
| Sep 30, 2022 | 799,475.00 |
| Jun 30, 2022 | 70,636.00 |
| Mar 31, 2022 | 54,913.00 |
| Dec 31, 2021 | 99,909.00 |
| Sep 30, 2021 | 70,275.00 |
| Jun 30, 2021 | 84,237.00 |
| Mar 31, 2021 | 503,337.00 |